OSI buys Osteometer MediTech
OSI Systems of Hawthorne, CA, reported last month that it has purchased Danish bone densitometry manufacturer Osteometer MediTech for $7.7 million. Osteometer MediTech offers DTX-200, a forearm dual-energy x-ray (DEXA) densitometer that has been cleared
OSI Systems of Hawthorne, CA, reported last month that it has purchased Danish bone densitometry manufacturer Osteometer MediTech for $7.7 million. Osteometer MediTech offers DTX-200, a forearm dual-energy x-ray (DEXA) densitometer that has been cleared by the Food and Drug Administration. The company also markets an ultrasound bone densitometer, DTU-1, in Europe. Osteometer MediTech applied for premarket approval (PMA) for the device in spring 1998. OSI hopes the deal will give it access to the medical subsystem market, according to executives at the optoelectronic devices company.
Emerging AI Mammography Model May Enhance Clarity for Initial BI-RADS 3 and 4 Classifications
May 21st 2025In a study involving over 12,000 Asian women, researchers found that an artificial intelligence (AI) model converted over 83 percent of false positives in patients with initial BI-RADS 3 and 4 assessments into benign BI-RADS categories.
Study: Abbreviated Breast MRI Offers Equivalent Accuracy to mpMRI for Women with Dense Breasts
May 20th 2025Emerging research suggests that abbreviated breast MRI offers comparable sensitivity and specificity as multiparametric MRI in women with extremely dense breasts with a nearly 50 percent reduction in reading time for radiologists.
Can AI Predict Future Lung Cancer Risk from a Single CT Scan?
May 19th 2025In never-smokers, deep learning assessment of single baseline low-dose computed tomography (CT) scans demonstrated a 79 percent AUC for predicting lung cancer up to six years later, according to new research presented today at the American Thoracic Society (ATS) 2025 International Conference.
